Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI

ETOP IBCSG Partners Foundation · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
egfr
non small cell lung cancer, egfr-mutant advanced non-squamous nsclc, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 911590
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.